Clinical Trial Update: Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing eltrombopag alone versus eltrombopag combined with rituximab in adults with primary immune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• Rituximab (rituximab)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Primary Immune Thrombocytopenia (ITP) | Phase 4 | Status: UNKNOWN